BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 2008;32:1404-11. [PMID: 18670347 DOI: 10.1097/PAS.0b013e31816bf41f] [Cited by in Crossref: 75] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Patel B, Klazynski B, Arora SP. High-Grade Large Cell Neuroendocrine Carcinoma: Case Report and Literature Review. J Gastrointest Cancer 2020;51:341-3. [PMID: 31254245 DOI: 10.1007/s12029-019-00267-0] [Reference Citation Analysis]
2 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
3 Terada T. Esophageal Carcinoma with Triplicate Differentiation into Squamous Cell Carcinoma, Small Cell Carcinoma and Adenocarcinoma: a Case Report. Gastroenterology Res 2009;2:118-21. [PMID: 27956965 DOI: 10.4021/gr2009.04.1282] [Reference Citation Analysis]
4 Mafficini A, Scarpa A. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Rev 2019;40:506-36. [PMID: 30657883 DOI: 10.1210/er.2018-00160] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
5 Hong L, Zhang Y, Liu Z. Neuroendocrine carcinoma of esophageal and gastric cardia: clinicopathologic and immunohistochemistry study of 80 cases. Oncotarget. 2018;9:10754-10764. [PMID: 29535841 DOI: 10.18632/oncotarget.23610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015;8:437-444. [PMID: 25709477 DOI: 10.2147/ott.s76048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
7 Liu S, Ge X, Gao Z, Zhou Q, Shi Y, Jiang W, Yang M, Sun X. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis. Medicine (Baltimore) 2021;100:e27302. [PMID: 34713821 DOI: 10.1097/MD.0000000000027302] [Reference Citation Analysis]
8 Kawazoe T, Saeki H, Edahiro K, Korehisa S, Taniguchi D, Kudou K, Nakanishi R, Kubo N, Ando K, Nakashima Y, Oki E, Fujiwara M, Oda Y, Maehara Y. A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett's esophagus: literature and review. Surg Case Rep 2018;4:45. [PMID: 29740725 DOI: 10.1186/s40792-018-0454-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yamamoto M, Ozawa S, Koyanagi K, Oguma J, Kazuno A, Ninomiya Y, Yatabe K, Hatanaka K. Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report. Surg Case Rep. 2018;4:56. [PMID: 29900476 DOI: 10.1186/s40792-018-0464-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khudiakov A, Al-Sadawi M, Qin J, Haddadin M, Soroka S, Hartt A, Soni L, Arora S, McFarlane SI. Rare Case of Rectal Mixed Adeno-Neuroendocrine Carcinoma. Am J Med Case Rep. 2019;7:117-120. [PMID: 31321296 DOI: 10.12691/ajmcr-7-6-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Reu S, Neumann J, Kirchner T. [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers]. Pathologe 2012;33:31-8. [PMID: 22293787 DOI: 10.1007/s00292-011-1552-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Abdelhakeem AA, Wang X, Waters RE, Patnana M, Estrella JS, Blum Murphy M, Trail AM, Lu Y, Devine CE, Ikoma N, Das P, Badgwell BD, Rogers JE, Ajani JA. Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response. Cancers (Basel) 2021;13:420. [PMID: 33498613 DOI: 10.3390/cancers13030420] [Reference Citation Analysis]
13 Mendoza-Moreno F, Díez-Gago MR, Mínguez-García J, Tallón-Iglesias B, Zarzosa-Hernández G, Fernández S, Solana-Maoño M, Argüello-De-Andrés JM. Mixed Adenoneuroendocrine Carcinoma of the Esophagus: A Case Report and Review of the Literature. Niger J Surg 2018;24:131-4. [PMID: 30283226 DOI: 10.4103/njs.NJS_43_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Deng HY, Li G, Luo J, Li XR, Alai G, Lin YD. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma. World J Surg. 2018;42:2428-2436. [PMID: 29340724 DOI: 10.1007/s00268-018-4475-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yuan G, Zhan C, Zhu D, Xie H, Wei T, Lu T, Yang Y, Zhu Y, Wang Q. Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015. J Thorac Dis 2019;11:5480-8. [PMID: 32030267 DOI: 10.21037/jtd.2019.11.34] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Schizas D, Mastoraki A, Kirkilesis GI, Sioulas AD, Papanikolaou IS, Misiakos EP, Arkadopoulos N, Liakakos T. Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management. J Gastrointest Cancer. 2017;48:299-304. [PMID: 28656561 DOI: 10.1007/s12029-017-9978-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhao K, Huang Z, Si Y, Sun L, Yu J, Meng X. Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus. Cancer Manag Res 2021;13:613-23. [PMID: 33531834 DOI: 10.2147/CMAR.S278914] [Reference Citation Analysis]
18 Doi S, Matsumoto S, Wakatsuki K, Migita K, Ito M, Kunishige T, Nakade H, Hatakeyama K, Ohbayashi C, Sho M. A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett's esophagus: a case report and literature review. Surg Case Rep 2018;4:103. [PMID: 30159830 DOI: 10.1186/s40792-018-0511-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Patel HD, Beck J, Kataria A, Gross GW, Echavarria J. Primary Large Cell Neuroendocrine Carcinoma of the Esophagus Disguised as a Food Impaction. ACG Case Rep J 2020;7:e00384. [PMID: 33062770 DOI: 10.14309/crj.0000000000000384] [Reference Citation Analysis]
20 Yuan W, Liu Z, Lei W, Sun L, Yang H, Wang Y, Ramdas S, Dong X, Xu R, Cai H, Li JZ, Ke Y. Mutation landscape and intra-tumor heterogeneity of two MANECs of the esophagus revealed by multi-region sequencing. Oncotarget 2017;8:69610-21. [PMID: 29050228 DOI: 10.18632/oncotarget.18678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
21 Babu Kanakasetty G, Dasappa L, Lakshmaiah KC, Kamath M, Jacob LA, Mallekavu SB, Rajeev LK, Haleshappa RA, Kadabur Nagendrappa L, Saldanha SC, Kumar RV. Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience. J Oncol. 2016;2016:2402417. [PMID: 27340404 DOI: 10.1155/2016/2402417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
22 Xiao Q, Xiao H, Ouyang S, Tang J, Zhang B, Wang H. Primary small cell carcinoma of the esophagus: Comparison between a Chinese cohort and Surveillance, Epidemiology, and End Results (SEER) data. Cancer Med. 2019;8:1074-1085. [PMID: 30740907 DOI: 10.1002/cam4.2001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
23 Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol 2020;96:8-33. [PMID: 31857137 DOI: 10.1016/j.humpath.2019.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
24 Kitajima T, Kaida S, Lee S, Haruta S, Shinohara H, Ueno M, Suyama K, Oota Y, Fujii T, Udagawa H. Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Oncol. 2013;11:218. [PMID: 24139488 DOI: 10.1186/1477-7819-11-218] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
25 Ye L, Lu H, Wu L, Zhang L, Shi H, Wu HM, Tu P, Li M, Wang FY. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases. BMC Cancer. 2019;19:1234. [PMID: 31852479 DOI: 10.1186/s12885-019-6420-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
26 Freis P, Graillot E, Rousset P, Hervieu V, Chardon L, Lombard-Bohas C, Walter T. Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers. Sci Rep. 2017;7:40609. [PMID: 28074897 DOI: 10.1038/srep40609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
27 Lee CG, Lim YJ, Park SJ, Jang BI, Choi SR, Kim JK, Kim YT, Cho JY, Yang CH, Chun HJ, Song SY; Neuroendocrine tumor study group. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea. BMC Cancer. 2014;14:569. [PMID: 25098730 DOI: 10.1186/1471-2407-14-569] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
28 Deng HY, Ni PZ, Wang YC, Wang WP, Chen LQ. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250-1256. [PMID: 27293844 DOI: 10.21037/jtd.2016.04.21] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
29 Tanaka Y, Hirata D, Fujii S, Kusaka T, Shibuya S. Early-stage Neuroendocrine Carcinoma of the Esophagus Observed with Annual Endoscopy for Three Years. Intern Med 2019;58:1727-31. [PMID: 30799355 DOI: 10.2169/internalmedicine.2151-18] [Reference Citation Analysis]
30 Wang H, Chen Y, Pi G, Zhu Y, Yang S, Mei H, Lin Z, Zhang T. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification. Oncol Lett. 2020;19:4122-4132. [PMID: 32382351 DOI: 10.3892/ol.2020.11480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Kaneko Y, Saito S, Takahashi K, Kanamaru R, Hosoya Y, Yamaguchi H, Kitayama J, Niki T, Lefor AK, Sata N. Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component. Clin J Gastroenterol 2019;12:534-8. [PMID: 31134449 DOI: 10.1007/s12328-019-00995-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) 2015;5:119-76. [PMID: 26854147 DOI: 10.3390/diagnostics5020119] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
33 Shi H, Qi C, Meng L, Yao H, Jiang C, Fan M, Pang S, Zhang Q, Lin R. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A SEER database analysis of 12,878 cases. Ther Adv Endocrinol Metab 2020;11:2042018820938304. [PMID: 32670540 DOI: 10.1177/2042018820938304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 La Rosa S, Marando A, Sessa F, Capella C. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel). 2012;4:11-30. [PMID: 24213223 DOI: 10.3390/cancers4010011] [Cited by in Crossref: 139] [Cited by in F6Publishing: 133] [Article Influence: 13.9] [Reference Citation Analysis]
35 Khonglah Y, Jitani AK, Gogoi BB, Hage N, Devi LP, Lynrah KG. Concurrent Lesions in Oesophagus: an Approach to Diagnosis with a Case Report. J Gastrointest Cancer 2017;48:201-4. [PMID: 27105636 DOI: 10.1007/s12029-016-9822-8] [Reference Citation Analysis]
36 Wang J, He A, Feng Q, Hou P, Wu J, Huang Z, Xiao Z, Sun C, Liao W, Wu L. Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends. J Transl Med. 2020;18:128. [PMID: 32169074 DOI: 10.1186/s12967-020-02293-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Saif MW, Vethody C. Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story. Cureus 2016;8:e646. [PMID: 27446766 DOI: 10.7759/cureus.646] [Cited by in F6Publishing: 3] [Reference Citation Analysis]